XOMA Co. (NASDAQ:XOMAO) Short Interest Up 33.3% in February

XOMA Co. (NASDAQ:XOMAO) was the recipient of a significant increase in short interest in the month of February. As of February 28th, there was short interest totalling 2,800 shares, an increase of 33.3% from the February 13th total of 2,100 shares. Based on an average daily trading volume, of 1,900 shares, the short-interest ratio is currently 1.5 days.

XOMA Stock Performance

NASDAQ:XOMAO opened at $25.45 on Friday. The firm has a 50-day simple moving average of $25.36 and a 200-day simple moving average of $25.44. XOMA has a one year low of $24.70 and a one year high of $25.87.

About XOMA

XOMA Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific. It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners; and acquires milestone and royalty revenue streams on late-stage clinical or commercial assets.